MONECO Advisors »

Denali Therapeutics shares owned by MONECO Advisors

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by MONECO Advisors from 13F filings

Historical chart of MONECO Advisors investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by MONECO Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by MONECO Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $202k 8.7k 23.22

More positions owned by MONECO Advisors

Apple (AAPL)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 100 Etf (OEF)
Microsoft Corporation (MSFT)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cambria Etf Tr Shshld Yield Etf (SYLD)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson & Johnson (JNJ)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Ishares Tr Msci Usa Min Vol (USMV)

View all positions for MONECO Advisors

Top funds holding Denali Therapeutics

Baillie Gifford & Co
BlackRock
Vanguard Group
State Street Corporation
Baker Bros. Advisors
Geode Capital Management
Marshall Wace
T. Rowe Price Associates
Alliancebernstein
Bank of New York Mellon
Dimensional Fund Advisors
Casdin Capital
Citadel Advisors
Morgan Stanley
Goldman Sachs Group

View all funds holding Denali Therapeutics